Guidance extended from year-end 2027 to early 2028, with operating expense reduction targets reiterated and achieved at a greater scale (now 35% year-over-year, 10% below guidance). Strategic focus ...

Sasha Stiles turned GPT-2 experiments into a self-writing poem at a Museum of Modern Art installation—and a new way to think about text-generating AI optimization ...

Need a quote from a Motley Fool analyst? Over the past decade, Recursion Pharmaceuticals, Inc. has built something truly special: a differentiated platform pioneering the integration of large-scale ...

Overview: The global Artificial Intelligence (AI) in drug discovery market is projected to grow at a rate of 25-30% over the ...

One of the fastest ways traders sabotage good setups isn’t bad entries — it’s unrealistic targets. In this quick video lesson from Senior Market Strategist John Rowland, CMT, he explains how Average ...

Amanda Smith is a freelance journalist and writer. She reports on culture, society, human interest and technology. Her stories hold a mirror to society, reflecting both its malaise and its beauty.

Whether you have pages of details for a work or school project, artificial intelligence can help you organize, summarize, and leverage your ideas more efficiently. These are the AI-infused note-taking ...

India, Feb. 14 -- A team of physicists from leading institutions has collaborated with OpenAI's GPT-5.2 model to achieve a new result in theoretical physics, the AI company announced.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...